Terms: = Lymphoma AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
106 results:
1. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
[TBL] [Abstract] [Full Text] [Related]
2. Bacterial heat shock protein genes during induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Dunn KA; MacDonald E; MacDonald T; Kulkarni K
Future Oncol; 2024 Jan; 20(1):17-23. PubMed ID: 38189148
[No Abstract] [Full Text] [Related]
3. Synergistic effect of hsp90 inhibitor ginkgolic acids C15
Ma H; Huang D; Li B; Ding F; Li H; Wu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1128-1135. PubMed ID: 37875353
[TBL] [Abstract] [Full Text] [Related]
4. A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting hsp90 and Its Client Proteins.
Nirgude S; Shahana M V ; Ravindran F; Kumar S; Sharma S; Mahadeva R; Mhatre A; Karki SS; Choudhary B
Molecules; 2023 Jul; 28(13):. PubMed ID: 37446888
[TBL] [Abstract] [Full Text] [Related]
5. The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
Karademir D; Özgür A
Med Oncol; 2023 Jul; 40(8):234. PubMed ID: 37432531
[TBL] [Abstract] [Full Text] [Related]
6. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
Ishikawa C; Mori N
Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
[TBL] [Abstract] [Full Text] [Related]
7. EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries.
Elshatlawy M; Sampson J; Clarke K; Bayliss R
Mol Oncol; 2023 Jun; 17(6):950-963. PubMed ID: 37149843
[TBL] [Abstract] [Full Text] [Related]
8. RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells.
Hong H; Luo B; Qin Y; Li S; Peng Z
Bioengineered; 2022 Mar; 13(3):7607-7621. PubMed ID: 35263200
[TBL] [Abstract] [Full Text] [Related]
9. hsp90 inhibition sensitizes DLBCL cells to cisplatin.
Schmidt L; Issa II; Haraldsdóttir H; Hald JL; Schmitz A; Due H; Dybkær K
Cancer Chemother Pharmacol; 2022 Apr; 89(4):431-440. PubMed ID: 35190872
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of adult T-cell leukemia cell proliferation by polymerized proanthocyanidin from blueberry leaves through JAK proteolysis.
Ichikawa T; Sugamoto K; Matsuura Y; Kunitake H; Shimoda K; Morishita K
Cancer Sci; 2022 Apr; 113(4):1406-1416. PubMed ID: 35100463
[TBL] [Abstract] [Full Text] [Related]
11. hsp90 inhibition downregulates DNA replication and repair genes via E2F1 repression.
Liu H; Lu Z; Shi X; Liu L; Zhang P; Golemis EA; Tu Z
J Biol Chem; 2021 Aug; 297(2):100996. PubMed ID: 34302809
[TBL] [Abstract] [Full Text] [Related]
12. Cell surface heat shock protein-mediated entry of tumor cell-adapted rotavirus into U-937 cells.
Rico J; Perez C; Hernandez J; Guerrero C; Acosta O
Folia Microbiol (Praha); 2021 Aug; 66(4):623-638. PubMed ID: 33950511
[TBL] [Abstract] [Full Text] [Related]
13. hsp90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias.
Mshaik R; Simonet J; Georgievski A; Jamal L; Bechoua S; Ballerini P; Bellaye PS; Mlamla Z; Pais de Barros JP; Geissler A; Francin PJ; Girodon F; Garrido C; Quéré R
Blood Cancer J; 2021 Mar; 11(3):61. PubMed ID: 33737511
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and biological significances of heat shock protein 90 (hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of hsp90 inhibitor.
Liu F; Wang L; Yi S; Liu Q; Xu X; Su M
Biomed Pharmacother; 2019 Dec; 120():109533. PubMed ID: 31634779
[TBL] [Abstract] [Full Text] [Related]
15. Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin hsp90 for activation.
Peiris MN; Meyer AN; Nelson KN; Bisom-Rapp EW; Donoghue DJ
Haematologica; 2020 May; 105(5):1262-1273. PubMed ID: 31439673
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.
Marrugal Á; Ferrer I; Pastor MD; Ojeda L; Quintanal-Villalonga Á; Carnero A; Molina-Pinelo S; Paz-Ares L
Cells; 2019 Jul; 8(8):. PubMed ID: 31370342
[TBL] [Abstract] [Full Text] [Related]
17. Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell-mediated remissions.
Dutt S; Atallah MB; Minamida Y; Filatenkov A; Jensen KP; Iliopoulou BP; Tamosiuniene R; Waters J; Engleman EG; Strober S
Blood Adv; 2018 Oct; 2(19):2568-2580. PubMed ID: 30301812
[TBL] [Abstract] [Full Text] [Related]
18. Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via hsp90.
Kuai Y; Gong X; Ding L; Li F; Lei L; Gong Y; Liu Q; Tan H; Zhang X; Liu D; Ren G; Pan H; Shi Y; Berberich-Siebelt F; Mao Z; Zhou R
Cell Commun Signal; 2018 Aug; 16(1):50. PubMed ID: 30143009
[TBL] [Abstract] [Full Text] [Related]
19. Activation of MYC, a bona fide client of hsp90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.
Lee J; Zhang LL; Wu W; Guo H; Li Y; Sukhanova M; Venkataraman G; Huang S; Zhang H; Alikhan M; Lu P; Guo A; Galanina N; Andrade J; Wang ML; Wang YL
Blood Adv; 2018 Aug; 2(16):2039-2051. PubMed ID: 30115641
[TBL] [Abstract] [Full Text] [Related]
20. BIIB021, an hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review).
He W; Hu H
Oncol Rep; 2018 Jul; 40(1):3-15. PubMed ID: 29749536
[TBL] [Abstract] [Full Text] [Related]
[Next]
